Publications 2022

Badie, A., Gaiddon, C., & Mellitzer, G. (2022). Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target? Cancers, 14(21), 5472.
Bersuder, E., Terciolo, C., Lechevrel, M., Martin, E., Quesnelle, C., Freund, J.-N., Reimund, J.-M., & Gross, I. (2022). Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 146, 112543.
Collard, M. K., Tourneur-Marsille, J., Uzzan, M., Albuquerque, M., Roy, M., Dumay, A., Freund, J.-N., Hugot, J.-P., Guedj, N., Treton, X., Panis, Y., & Ogier-Denis, E. (2022). The appendix orchestrates T-cell mediated immunosurveillance in colitis-associated cancer. Cellular and Molecular Gastroenterology and Hepatology, S2352-345X(22)00230-2.
De Azevedo, J., Mourtada, J., Bour, C., Devignot, V., Schultz, P., Borel, C., Pencreach, E., Mellitzer, G., Gaiddon, C., & Jung, A. C. (2022). The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response. Cells, 11(18), 2866.
Delhorme, J.-B., Bersuder, E., Terciolo, C., Vlami, O., Chenard, M.-P., Martin, E., Rohr, S., Brigand, C., Duluc, I., Freund, J.-N., & Gross, I. (2022). CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 147, 112630.
Giolito, M. V., & Plateroti, M. (2022). Thyroid hormone signaling in the intestinal stem cells and their niche. Cellular and Molecular Life Sciences: CMLS, 79(9), 476.
Goïta, A. A., & Guenot, D. (2022). Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7. Cancers, 14(7), 1810.
Passet, M., Kim, R., Gachet, S., Sigaux, F., Chaumeil, J., Galland, A., Sexton, T., Quentin, S., Hernandez, L., Larcher, L., Bergugnat, H., Ye, T., Karasu, N., Caye-Eude, A., Heizmann, B., Duluc, I., Chevallier, P., Rousselot, P., Huguet, F., … Clappier, E. (2022). Concurrent CDX2 cis-deregulation and UBTF-ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL. Blood, blood.2021014723.
Sirakov, M., & Plateroti, M. (2022). Thyroid Hormone Signaling and Function: News from Classical and Emerging Models. Cells, 11(3), 453.
Venkatasamy, A., Guerin, E., Reichardt, W., Devignot, V., Chenard, M. P., Miguet, L., Romain, B., Jung, A. C., Gross, I., Gaiddon, C., & Mellitzer, G. (2022). Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia. Gastric Cancer.